OGT Licenses Microarray IP to Invitrogen | GenomeWeb
NEW YORK (GenomeWeb News) - Oxford Gene Technology has licensed its oligonucleotide microarray patents to Invitrogen, OGT said today.
 
With the license, Invitrogen can offer DNA related microarray services to customers worldwide from its US operations.
 
The license will remain valid for the patents’ lifetime.
 
Financial details were not disclosed.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.